These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11274672)

  • 1. Tyrosine improves behavioral and neurochemical deficits caused by cold exposure.
    Yeghiayan SK; Luo S; Shukitt-Hale B; Lieberman HR
    Physiol Behav; 2001 Feb; 72(3):311-6. PubMed ID: 11274672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-tyrosine on mixed-acting sympathomimetic-induced pressor actions.
    Hull KM; Maher TJ
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1047-52. PubMed ID: 1475286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine prevents effects of hyperthermia on behavior and increases norepinephrine.
    Lieberman HR; Georgelis JH; Maher TJ; Yeghiayan SK
    Physiol Behav; 2005 Jan; 84(1):33-8. PubMed ID: 15642604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment.
    Florin SM; Kuczenski R; Segal DS
    Brain Res; 1994 Aug; 654(1):53-62. PubMed ID: 7982098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protracted 'pro-addictive' phenotype produced in mice by pre-adolescent phenylpropanolamine.
    Szumlinski KK; Liu A; Penzner JH; Lominac KD
    Neuropsychopharmacology; 2007 Aug; 32(8):1760-73. PubMed ID: 17251912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats.
    McTavish SF; Raumann B; Cowen PJ; Sharp T
    Eur J Pharmacol; 2001 Jul; 424(2):115-9. PubMed ID: 11476757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
    Berridge CW; Stalnaker TA
    Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical evaluation of phenylpropanolamine.
    Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-tyrosine fails to potentiate several peripheral actions of the sympathomimetics.
    Hull KM; Maher TJ
    Pharmacol Biochem Behav; 1991 Jul; 39(3):755-9. PubMed ID: 1784604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine prevents behavioral and neurochemical correlates of an acute stress in rats.
    Reinstein DK; Lehnert H; Scott NA; Wurtman RJ
    Life Sci; 1984 Jun; 34(23):2225-31. PubMed ID: 6727560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
    Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M
    Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.
    Hull KM; Maher TJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):403-9. PubMed ID: 2243331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain.
    Le Masurier M; Oldenzeil W; Lehman C; Cowen P; Sharp T
    Neuropsychopharmacology; 2006 Feb; 31(2):310-7. PubMed ID: 16034439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent effects of repeated amphetamine treatment on norepinephrine in the hypothalamus and hippocampus assessed with in vivo microdialysis.
    Camp DM; DeJonghe DK; Robinson TE
    Neuropsychopharmacology; 1997 Sep; 17(3):130-40. PubMed ID: 9272480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice.
    Barbier E; Zapata A; Oh E; Liu Q; Zhu F; Undie A; Shippenberg T; Wang JB
    Neuropsychopharmacology; 2007 Aug; 32(8):1774-82. PubMed ID: 17203012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted 'anti-addictive' effects of adolescent phenylpropanolamine exposure in C57BL/6J mice.
    Penzner JH; Thompson DL; Arth C; Fowler JK; Ary AW; Szumlinski KK
    Addict Biol; 2008 Sep; 13(3-4):310-25. PubMed ID: 18331369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood.
    Labonte B; McLaughlin RJ; Dominguez-Lopez S; Bambico FR; Lucchino I; Ochoa-Sanchez R; Leyton M; Gobbi G
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1319-30. PubMed ID: 22053980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
    Cancela LM; Basso AM; Martijena ID; Capriles NR; Molina VA
    Brain Res; 2001 Aug; 909(1-2):179-86. PubMed ID: 11478934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.
    Imperato A; Obinu MC; Carta G; Mascia MS; Casu MA; Gessa GL
    Eur J Pharmacol; 1996 Dec; 317(2-3):231-7. PubMed ID: 8997605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.